Darja Schmidt

3.0k total citations
42 papers, 2.3k citations indexed

About

Darja Schmidt is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Darja Schmidt has authored 42 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Virology and 11 papers in Immunology. Recurrent topics in Darja Schmidt's work include Poxvirus research and outbreaks (10 papers), Immunotherapy and Immune Responses (8 papers) and Ubiquitin and proteasome pathways (6 papers). Darja Schmidt is often cited by papers focused on Poxvirus research and outbreaks (10 papers), Immunotherapy and Immune Responses (8 papers) and Ubiquitin and proteasome pathways (6 papers). Darja Schmidt collaborates with scholars based in Germany, United States and France. Darja Schmidt's co-authors include Stefan Müller, Paul Chaplin, M Reiser, Urs D. Schmid, A. Jassoy, Tarek Yousry, Heinz Weidenthaler, Wilhelm Eisner, H. J. Reulen and Günter Silbernagl and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Darja Schmidt

40 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darja Schmidt Germany 20 1.5k 516 434 430 355 42 2.3k
F. Murata United States 23 879 0.6× 309 0.6× 236 0.5× 553 1.3× 274 0.8× 96 2.4k
Hervé Perron France 41 2.4k 1.7× 266 0.5× 1.3k 3.0× 658 1.5× 188 0.5× 100 4.8k
Paul Dazin United States 28 1.6k 1.1× 565 1.1× 552 1.3× 327 0.8× 296 0.8× 49 3.0k
Xiao-Jun Ma United States 9 1.2k 0.8× 446 0.9× 248 0.6× 271 0.6× 53 0.1× 9 2.5k
Minh Nguyen United States 12 1.9k 1.3× 655 1.3× 385 0.9× 272 0.6× 189 0.5× 21 3.0k
Gary Hermanson United States 22 1.6k 1.1× 236 0.5× 891 2.1× 266 0.6× 126 0.4× 32 2.7k
Donna L. Mallery United Kingdom 24 1.4k 1.0× 307 0.6× 833 1.9× 353 0.8× 396 1.1× 29 2.9k
Manley Huang United States 17 1.1k 0.8× 398 0.8× 692 1.6× 243 0.6× 55 0.2× 28 2.1k
Lorraine M. Albritton United States 25 983 0.7× 429 0.8× 782 1.8× 344 0.8× 625 1.8× 44 2.6k
Harald Petry Germany 37 1.9k 1.3× 647 1.3× 354 0.8× 480 1.1× 516 1.5× 93 3.4k

Countries citing papers authored by Darja Schmidt

Since Specialization
Citations

This map shows the geographic impact of Darja Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darja Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darja Schmidt more than expected).

Fields of papers citing papers by Darja Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darja Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darja Schmidt. The network helps show where Darja Schmidt may publish in the future.

Co-authorship network of co-authors of Darja Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Darja Schmidt. A scholar is included among the top collaborators of Darja Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darja Schmidt. Darja Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jenkins, Victoria A., Günter Silbernagl, Darja Schmidt, et al.. (2024). A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study. Vaccine. 42(26). 126427–126427. 7 indexed citations
3.
Schultz, Stephanie A., Günter Silbernagl, Darja Schmidt, et al.. (2023). Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine. The Journal of Infectious Diseases. 228(8). 999–1011. 18 indexed citations
4.
5.
6.
Lawrence, Steven J., Thomas Meyer, Darja Schmidt, et al.. (2020). Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine. The Journal of Infectious Diseases. 223(6). 1062–1072. 46 indexed citations
7.
Overton, Edgar T., Steven J. Lawrence, Jack T. Stapleton, et al.. (2020). A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS. Vaccine. 38(11). 2600–2607. 46 indexed citations
8.
Overton, Edgar T., Steven J. Lawrence, Eva Wagner, et al.. (2018). Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial. PLoS ONE. 13(4). e0195897–e0195897. 42 indexed citations
9.
Greenberg, Richard N., Christine M. Hay, Jack T. Stapleton, et al.. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PLoS ONE. 11(6). e0157335–e0157335. 54 indexed citations
10.
Greenberg, Richard N., Alfred von Krempelhuber, Garth Virgin, et al.. (2015). A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE. 10(10). e0138348–e0138348. 77 indexed citations
11.
Schmidt, Darja, Karsten Mahnke, Martin F. Bachmann, et al.. (2008). Constitutive Crosspresentation of Tissue Antigens by Dendritic Cells Controls CD8+ T Cell Tolerance In Vivo. Immunity. 28(4). 521–532. 113 indexed citations
12.
Mziaut, Hassan, Mirko Trajkovski, Stephan Kersting, et al.. (2006). Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nature Cell Biology. 8(5). 435–445. 73 indexed citations
13.
Bossis, Guillaume, Cécile E. Malnou, Rosa Farrás, et al.. (2005). Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation. Molecular and Cellular Biology. 25(16). 6964–6979. 161 indexed citations
14.
Schmidt, Darja, et al.. (2005). Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene. 24(23). 3810–3818. 85 indexed citations
15.
Schmidt, Darja, et al.. (2003). PIAS/SUMO: new partners in transcriptional regulation. Cellular and Molecular Life Sciences. 60(12). 2561–2574. 227 indexed citations
16.
Engelke, Klaus, et al.. (2002). Diagnostic agreement of two calcaneal ultrasound devices: the Sahara bone sonometer and the Achilles+. British Journal of Radiology. 75(899). 895–902. 12 indexed citations
17.
Yousry, Tarek, Urs D. Schmid, Darja Schmidt, et al.. (1996). The central sulcal vein: a landmark for identification of the central sulcus using functional magnetic resonance imaging. Journal of neurosurgery. 85(4). 608–617. 41 indexed citations
18.
Yousry, Tarek, Urs D. Schmid, A. Jassoy, et al.. (1995). Topography of the cortical motor hand area: prospective study with functional MR imaging and direct motor mapping at surgery.. Radiology. 195(1). 23–29. 205 indexed citations
19.
Fales, William H., et al.. (1990). Successful treatment of feline cryptococcosis with ketaconazole and flucytosine.. Journal of the American Animal Hospital Association. 26(2). 199–201. 10 indexed citations
20.
Höglund, Mattias, C. Muren, & Darja Schmidt. (1989). Caroli's Disease in Two Sisters. Acta Radiologica. 30(5). 459–462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Murata Breakdown of academic impact, for papers by Hervé Perron Breakdown of academic impact, for papers by Paul Dazin Breakdown of academic impact, for papers by Xiao-Jun Ma Breakdown of academic impact, for papers by Minh Nguyen Breakdown of academic impact, for papers by Gary Hermanson Breakdown of academic impact, for papers by Donna L. Mallery Breakdown of academic impact, for papers by Manley Huang Breakdown of academic impact, for papers by Lorraine M. Albritton Breakdown of academic impact, for papers by Harald Petry
Rankless by CCL
2026